Dendritic cells and CD8 T cell immunity in tumor microenvironment

C Fu, A Jiang - Frontiers in immunology, 2018 - frontiersin.org
Dendritic cells (DCs) play a central role in the regulation of the balance between CD8 T cell
immunity vs. tolerance to tumor antigens. Cross-priming, a process which DCs activate CD8 …

DC-based vaccines for cancer immunotherapy

C Fu, L Zhou, QS Mi, A Jiang - Vaccines, 2020 - mdpi.com
As the sentinels of the immune system, dendritic cells (DCs) play a critical role in initiating
and regulating antigen-specific immune responses. Cross-priming, a process that DCs …

Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells

B Ruffell, D Chang-Strachan, V Chan, A Rosenbusch… - Cancer cell, 2014 - cell.com
Blockade of colony-stimulating factor-1 (CSF-1) limits macrophage infiltration and improves
response of mammary carcinomas to chemotherapy. Herein we identify interleukin (IL)-10 …

DC-derived exosomes for cancer immunotherapy

Y Yao, C Fu, L Zhou, QS Mi, A Jiang - Cancers, 2021 - mdpi.com
Simple Summary Dendritic cells (DCs)-based cancer vaccines have not succeeded in
generating significant clinical responses despite their capacity to induce host anti-tumor …

Synthetic immune niches for cancer immunotherapy

J Weiden, J Tel, CG Figdor - Nature Reviews Immunology, 2018 - nature.com
Cancer immunotherapy can successfully promote long-term anticancer immune responses,
although there is still only a limited number of patients who benefit from such treatment, and …

Tertiary lymphoid structures in cancer: the double-edged sword role in antitumor immunity and potential therapeutic induction strategies

W Kang, Z Feng, J Luo, Z He, J Liu, J Wu… - Frontiers in …, 2021 - frontiersin.org
The complex tumor microenvironment (TME) plays a vital role in cancer development and
dramatically determines the efficacy of immunotherapy. Tertiary lymphoid structures (TLSs) …

Dendritic cell-based vaccines against cancer: challenges, advances and future opportunities

C Fu, T Ma, L Zhou, QS Mi, A Jiang - Immunological investigations, 2022 - Taylor & Francis
As the most potent professional antigen presenting cells, dendritic cells (DCs) have the
ability to activate both naive CD4 and CD8 T cells. Recognized for their exceptional ability to …

Cell and tissue engineering in lymph nodes for cancer immunotherapy

AJ Najibi, DJ Mooney - Advanced drug delivery reviews, 2020 - Elsevier
In cancer, lymph nodes (LNs) coordinate tumor antigen presentation necessary for effective
antitumor immunity, both at the levels of local cellular interactions and tissue-level …

Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment

AM Weinstein, L Chen, EA Brzana, PR Patil… - …, 2017 - Taylor & Francis
We have previously reported that direct injection of dendritic cells (DC) engineered to
express the Type-1 transactivator Tbet (ie, DC. Tbet) into murine tumors results in antitumor …

Inducible tertiary lymphoid structures: promise and challenges for translating a new class of immunotherapy

S Aoyama, R Nakagawa, JJ Mulé… - Frontiers in …, 2021 - frontiersin.org
Tertiary lymphoid structures (TLS) are ectopically formed aggregates of organized
lymphocytes and antigen-presenting cells that occur in solid tissues as part of a chronic …